CAS: 40828-46-4; 2-(4-(Thiophene-2-Carbonyl)Phenyl)Propanoic Acid

该化合物是一种主要用于其止痛和抗炎特性的非类固醇抗炎药物(NSAID),其特征是能够抑制酶环氧酶(COX),该酶在合成plestalandins,介质炎和疼痛的化合物方面起着关键作用. Suprofen经常用于治疗关节炎和其他炎症等病症.Suprofen的化学结构包括一种有助于其药理活动的丙基酸混合物.它通常通过口服进行,以相对快速的行动为人知.然而,同其他NSAID一样, Suprofen可能与胃肠侧效应,心血管风险和肾损伤有关,特别是长期使用.它的安全特征需要预先存在病症的病人仔细考虑.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号201230-82-2 carbon monoxide | CAS号79204-44-7 4-vinylphenyl 2... | CAS号52779-57-4 diethyl methyl[... | CAS号52779-85-8 2-[4-(thiophene... | CAS号74-88-4 碘甲烷 | CAS号1003-09-4 2-溴噻吩 | CAS号2156-04-9 对乙烯基苯基硼酸 | CAS号51022-75-4 克利洛芬 | CAS号144-62-7 草酸 | CAS号52779-81-4 4-ethylphenyl 2... | CAS号52779-97-2 sodium 2-[4-(2-...

合成工艺路线路线简述

    📜克利洛芬 反应生成 舒洛芬
    参考文献:Topical Anti-Inflammatory Drug Therapy
    标题:Topical Anti-Inflammatory Drug Therapy
    摘要:一种用于治疗皮肤炎症或过度增生的表皮活动的局部皮肤疾病的药物组合物,其特征在于包括一种具有局部活性的抗炎糖皮质激素和一种非甾体抗炎药物,该非甾体抗炎药物为前列腺素合成酶抑制剂,所述前列腺素合成酶抑制剂选自羟基环戊酸衍生物;乙酰水杨酸;吡唑酮衍生物;芬酸衍生物;芳基取代吡咯烷和取代芳基乙酰羟肟酸之类的化合物,所述药物组合物为药学可接受的局部载体.同时使用皮质激素和非甾体抗炎药物的单独应用也可治疗上述皮肤疾病.

    海关参考信息

    专利信息


    专利号:WO-9837078-A1
    优先权日:1997-02-20
    标题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest. The thiophenes are prepared by reaction of a substrate-bound primary or secondary amine with a thiophosgene equivalent and reaction of the resulting intermediate with an acceptor-substituted acetonitrile in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegler-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-2024287520-A1
    优先权日:2021-06-30
    标题:Method for synthesis of linkage modified oligomeric compounds
    发明人:RODRIGUEZ ANDREW A
    权利人:IONIS PHARMACEUTICALS INC
    摘要:The present disclosure provides methods of synthesizing modified oligonucletodies and oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified internucleoside linking group. In certain embodiments, the present disclosure provides stabilized formulations of certain sulfonyl azides for use in the synthesis of olignonucleotides comprising one or more sulfonyl phosphoramidate linkages. Some embodiments provide stabilized compositions of high energy reagents that may be used in the synthesis of modified oligonucleotides, allowing for safe process scale preparation thereof.

    专利号:US-2004242897-A1
    优先权日:2002-07-31
    标题 :Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    专利号:US-6136984-A
    优先权日:1996-04-22
    标 题 :Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
    发明人:DOERWALD FLORENCIO ZARAGOZA
    权利人:NOVO NORDISK AS
    摘要:A solid phase method for the synthesis of a plurality of differently substituted thiophenes with a wide variety of side-chain substituents as compounds of potential therapeutic interest is disclosed. The thiophenes are prepared by acylation of a substrate-bound primary or secondary amine with cyanoacetic acid and reaction of the resulting cyanoacetamide with an isothiocyanate in the presence of a base. Alkylation with an appropriate alkyl halide, followed by Thorpe-Ziegier-cyclization yields differently substituted, support-bound 3-aminothiophenes. These may be screened on the substrate or cleaved from the substrate and then screened in solution. Alternatively, the resin-bound 3-amino thiophenes or the synthetic intermediates can be subjected to further synthetic transformations (N-acylation, reduction) on the support, which permits the preparation of further therapeutically interesting compounds. The efficient synthesis of a wide variety of thiophenes using automated synthesis technology of the present method makes these compounds attractive candidates for the generation and rapid screening of diverse thiophene-based libraries. The method disclosed here provides an easy and fast access to highly diverse heterocyclic compounds of therapeutic interest, amenable to automatization.

    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:WO-2004011474-A1
    优先权日:2002-07-31
    标题:Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Rosan T, Ljubojević Hadžavdić S. Ketoprofen-induced Photoallergic Reaction. Acta Dermatovenerol Croat. 2022 Nov;30(3):197-198. 23(15):1514-1534. doi: 10.2174/1389557523666230206104257. 32(3):10781. doi: 10.4081/ejtm.2022.10781.
    4: Musa KAK, Eriksson LA. Computational Studies of the Photodegradation Mechanism of the Highly Phototoxic Agent Benoxaprofen. ACS Omega. 2022 Aug 11;7(33):29475-29482. doi: 10.1021/acsomega.2c03118.
    5: Zielinski K, Sekula B, Bujacz A, Szymczak I. Structural investigations of stereoselective profen binding by equine and leporine serum albumins. Chirality. 2020 Mar;32(3):334-344. doi: 10.1002/chir.23162. Epub 2020 Jan 6.

    合成参考文献


    摘要:Clarke, M. L.; Fuentes, J. A., Science of Synthesis: C-1 Building Blocks in Organic Synthesis, (2013) 1, 232.
    摘要:Arzneimittel-Forschung. Drug Research., 25(1597), 1975
    摘要:Drug Intelligence and Clinical Pharmacy., 20(860), 1986 []
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知